Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing.
Dhakal B, Li CMY, Li R, Yeo K, Wright JA, Gieniec KA, Vrbanac L, Sammour T, Lawrence M, Thomas M, Lewis M, Perry J, Worthley DL, Woods SL, Drew P, Sallustio BC, Smith E, Horowitz JD, Maddern GJ, Licari G, Fenix K. Dhakal B, et al. Cancers (Basel). 2022 Feb 18;14(4):1043. doi: 10.3390/cancers14041043. Cancers (Basel). 2022. PMID: 35205791 Free PMC article.
Outcomes of Older Adults and Frail Patients Receiving Idecabtagene Vicleucel: A CIBMTR Study.
Akhtar OS, Oloyede T, Brazauskas R, Afrough A, Hashmi H, Sidana S, Ahmed N, Bye M, Hansen DK, Ferreri CJ, Dhakal B, Dhanda DS, Harrison MJ, Kitali A, Landau HJ, Mirza AS, Patel J, Patwardhan P, Qazilbash MH, Patel KK, Nishihori T, Ganguly S, Gowda L, Anderson LD Jr, Pasquini MC, Usmani SZ, Freeman CL. Akhtar OS, et al. Among authors: dhakal b. Blood Adv. 2024 Dec 30:bloodadvances.2024014970. doi: 10.1182/bloodadvances.2024014970. Online ahead of print. Blood Adv. 2024. PMID: 39786391
Characteristics and outcomes in patients with lenalidomide-refractory multiple myeloma treated with 1-3 prior lines of therapy: Analysis of individual patient-level data from daratumumab clinical trials.
Yong K, Einsele H, Schecter JM, Roccia T, Deraedt W, Lendvai N, Slaughter A, Lonardi C, Connors K, Qi K, Londhe A, Carson R, Kharat A, Cost P, Valluri S, Mendes J, Pacaud L, Patel N, Florendo E, Dhakal B. Yong K, et al. Among authors: dhakal b. Eur J Cancer. 2025 Jan 17;215:115157. doi: 10.1016/j.ejca.2024.115157. Epub 2024 Nov 29. Eur J Cancer. 2025. PMID: 39673835
Prediction of the outcome of intracerebral hemorrhage by blood neutrophil to lymphocyte ratio: a prospective observational study.
Shrestha G, Gurung A, Sedhain G, Bajpai S, Hamal A, Verma R, Bashyal B, Shrestha A, Dhakal B, Shrestha A, Acharya R, Neupane A, Bhandari S. Shrestha G, et al. Among authors: dhakal b. Ann Med Surg (Lond). 2024 Sep 17;86(11):6472-6476. doi: 10.1097/MS9.0000000000002554. eCollection 2024 Nov. Ann Med Surg (Lond). 2024. PMID: 39525717 Free PMC article.
297 results